Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2383]
News [3465]
Articles [286]
Editorials [30]
Conferences [173]
elearning [101]
Inequalities in immuno-oncology access across Europe
Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium
Inequalities in immuno-oncology access across Europe ( Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium )
14 Dec 2017
Measuring innovation and value in healthcare systems
Dr Iñaki Gutiérrez-Ibarluzea - Vice President in Health Technology Assessment...
Measuring innovation and value in healthcare systems ( Dr Iñaki Gutiérrez-Ibarluzea - Vice President in Health Technology Assessment International (HTAi), Basque Region, Spain )
14 Dec 2017
Could personalised medicine increase inequality to medicine access?
Dr Stanimir Hasurdjiev - Bulgarian National Patients’ Organization, Sofia...
Could personalised medicine increase inequality to medicine access? ( Dr Stanimir Hasurdjiev - Bulgarian National Patients’ Organization, Sofia, Bulgaria )
14 Dec 2017
The economics of personalised medicine in low and middle income countries
Prof Sue Horton - University of Waterloo, Waterloo, Canada
The economics of personalised medicine in low and middle income countries ( Prof Sue Horton - University of Waterloo, Waterloo, Canada )
14 Dec 2017
Creating a culture of shared data
Prof Mark Lawler - Queen's University Belfast, Belfast, Ireland
Creating a culture of shared data ( Prof Mark Lawler - Queen's University Belfast, Belfast, Ireland )
14 Dec 2017
Accelerating research to the bedside
Brian O'Connor - European Connected Health Alliance
Accelerating research to the bedside ( Brian O'Connor - European Connected Health Alliance )
14 Dec 2017
Next generation sequencing identifies smoldering multiple myeloma patients with...
Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression ( Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2017
The Innovative Medicines Initiative
Dr Pierre Meulien - Innovation Medicines Initiative, Brussels, Belgium
The Innovative Medicines Initiative ( Dr Pierre Meulien - Innovation Medicines Initiative, Brussels, Belgium )
14 Dec 2017
Venetoclax plus rituximab for patients with relapsed / refractory CLL
Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Venetoclax plus rituximab for patients with relapsed / refractory CLL ( Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2017
Daratumumab for patients with multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Daratumumab for patients with multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
12 Dec 2017
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib...
Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Dec 2017
ASH 2017: Immunotherapy for multiple myeloma
Prof Paul Richardson & Dr Wenming Chen
ASH 2017: Immunotherapy for multiple myeloma ( Prof Paul Richardson & Dr Wenming Chen )
12 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation